OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs
Judith I. Tsui, Michael P. Barry, Elizabeth J. Austin, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis
Mark J Hayes, Emma Beavon, Michael W. Traeger, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102489-102489
Open Access | Times Cited: 4

Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma
Elizabeth J. Austin, Judith I. Tsui, Michael P. Barry, et al.
Journal of Substance Abuse Treatment (2021) Vol. 137, pp. 108684-108684
Open Access | Times Cited: 25

Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program
Dorothy E. Loy, Kevin Kamis, Ruth Kanatser, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 3

Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care
Elena M. Soyer, Madeline C. Frost, Olivia V. Fletcher, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2

Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs
Elizabeth J. Austin, Alexander J. Gojic, Elenore P. Bhatraju, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103924-103924
Open Access | Times Cited: 9

Caring for patients with substance use disorders: a qualitative investigation of difficulties encountered by hospital-based clinicians
Sophie Paroz, Martine Monnat, Francesco Panese, et al.
Journal of Addictive Diseases (2023) Vol. 43, Iss. 1, pp. 12-23
Open Access | Times Cited: 5

Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs
J.I. Tsui, Alex J. Gojic, Kerry A. Pierce, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 10, pp. 100213-100213
Open Access | Times Cited: 4

Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
Patrik Roser, Mona Brunstein, Michael Specka, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1

Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center
Jessica M. Downes, Anthony Donovan, Carrie McAdam‐Marx
Journal of the American Pharmacists Association (2022) Vol. 62, Iss. 5, pp. 1596-1605
Closed Access | Times Cited: 7

Prevalence of social and economic stressors among transgender veterans with alcohol and other drug use disorders
Olivia V. Fletcher, Jessica Chen, Jenna van Draanen, et al.
SSM - Population Health (2022) Vol. 19, pp. 101153-101153
Open Access | Times Cited: 6

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Tony Antoniou, Cheryl Pritlove, Dana Shearer, et al.
International Journal for Equity in Health (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Indications of food insecurity in the content of telephone calls to a community referral system
Nasser Sharareh, Ching‐Yu Wang, Andrea S. Wallace, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284624-e0284624
Open Access | Times Cited: 1

Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019
Shelley N. Facente, Rachel Grinstein, Roberta Bruhn, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0267902-e0267902
Open Access | Times Cited: 2

Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA
Michael P. Barry, Elizabeth J. Austin, Elenore P. Bhatraju, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 2

Behandling av hepatitt C og endringer i rusmiddelbruk – en kvalitativ studie
Karoline A. Olsen-Søviknes, Lennart Lorås, Lars Thore Fadnes, et al.
Sykepleien Forskning (2023), Iss. 91190, pp. e-91190
Open Access

Treatment of hepatitis C and changes in substance use – a qualitative study
Karoline A. Olsen-Søviknes, Lennart Lorås, Lars Thore Fadnes, et al.
Sykepleien Forskning (2023), Iss. 91190, pp. e-91190
Open Access

High Seroprevalence of Hepatitis C Virus Among Cisgender Women Who Exchange Sex in the Seattle, Washington Area
Michael P. Barry, Maria A. Corcorran, Judith I. Tsui, et al.
Substance Use & Addiction Journal (2023) Vol. 45, Iss. 1, pp. 81-90
Closed Access

Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019
Shelley N. Facente, Rachel Grinstein, Roberta Bruhn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access

Page 1

Scroll to top